Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Milestone® Pharmaceuticals Announces Data Presentations on Etripamil at Heart Rhythm 2024, 2024 Stanford BioDesign Arrhythmia Technologies Retreat, and ISPOR 2024
-
Enphase Energy Expands Deployments of Enphase Energy System with IQ Battery 5P in Florida
-
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm
-
Rentschler Biopharma Appoints Patrick Cushing as VP Operations for U.S. Subsidiary
-
Mineralys Therapeutics to Announce First Quarter 2024 Financial Results and Host Conference Call on Thursday, May 9, 2024
-
SPAR Group Announces Closing of South Africa Joint Venture Sale
-
VoIP-Pal Receives a Favorable Ruling in the Northern District of Texas
-
Inaugural Mizuho DrivHER Summit at the Mizuho Americas Open to Inspire the New Generation of Women Leaders
-
Two Six Technologies Announces Participation in Department of Commerce Consortium Dedicated to AI Safety
-
Collective Metals Provides Review of Trojan-Condor Target Area on its Princeton Copper Project in B.C.
-
Intuity Medical’s POGO Automatic®, the First and Only FDA-Cleared Automatic Blood Glucose Monitor, Now Covered by Medicare Part B
-
PDS Biotech Appoints Stephan Toutain as Chief Operating Officer
-
Aqua Security Releases Industry-First Solution to Secure Large Language Model (LLM)-Based Applications from Code to Cloud
-
XpresSpa Introduces IV Hydration Drip Therapy at Miami International Airport
-
Registration is Now Open for Microchip’s 24th Annual Worldwide MASTERs Conference in Scottsdale, Arizona
-
LifeMD Becomes the First Virtual Primary Care Provider to Elevate GLP-1 Patient Care with Real-time, At-Home Monitoring of Blood Pressure and Body Composition
-
Kawasaki Robotics Shares First Look of New Collaborative Robots, Features New Partnerships and Applications for Industrial Robots at AUTOMATE 2024
-
Data and AI Consultancy Indicium Scales with $40 Million Investment from Columbia Capital
-
Taysha Gene Therapies Announces Regenerative Medicine Advanced Therapy (RMAT) Designation Granted by U.S. FDA for TSHA-102 in Rett Syndrome
-
Protara Therapeutics Announces First Quarter 2024 Financial Results and Provides Business Update
-
WELL Launches its Second-Generation AI powered Physician Co-pilot with Chronic Disease Detection Powered by HEALWELL AI
-
Official Announcement: $DEDE, the New Dino-Themed Meme Coin on Solana Blockchain
-
AskBio Announces Nine Presentations at American Society of Gene and Cell Therapy 27th Annual Meeting 2024
-
CDT Environmental Technology Investment Holdings Limited Receives Three New Utility Model Patent Allowances from the China National Intellectual Property Administration (CNIPA)
-
Fengate adds six seniors housing facilities to its U.S. healthcare and seniors housing portfolio
-
NewAmsterdam Pharma to Host R&D Day with Key Opinion Leaders on May 16, 2024
-
Dremio and VAST Data Build the First Zero Trust Data Lakehouse Platform - Sets a New Standard for Data Security and Accessibility
-
TeraWulf Announces April 2024 Production and Operations Update
-
Provectus Biopharmaceuticals Announces Notice of Allowance for U.S. Patent of Oral Administration of Rose Bengal Sodium in Hematology (Leukemia)
-
Super League Sets First Quarter 2024 Earnings Date, May 15, 2024
-
Positive Initial Clinical Data Reported from Immutep’s Efti Combined with Radiotherapy and Checkpoint Inhibitor from Phase II Trial in Soft Tissue Sarcoma
-
Recursion to Report First Quarter 2024 Business Updates and Financial Results on May 9
-
Northann Corp.'s Blue11-Ocean Plastic Flooring and Wall Panels Product Wins Multiple Prestigious Awards in 2024
-
Duos Granted Comprehensive Patent for Railcar Scanning
-
Mangoceuticals Granted 180-Day Extension to Meet Nasdaq Minimum Bid Price Requirement and Conditional Approval of Compliance with Nasdaq’s Minimum Stockholders’ Equity Requirement
-
Oxford Square Capital Corp. Announces Net Asset Value and Selected Financial Results for the Quarter Ended March 31, 2024 and Declaration of Distributions on Common Stock for the Months Ending July 31
-
LVT Hires Mark Cranney as Chief Revenue Officer
-
Science 37 Delivers 22x Faster Enrollment than Traditional Methods in Phase 3 Asthma Clinical Trial
-
PDS Biotech Appoints Stephan Toutain as Chief Operating Officer
-
Shape Therapeutics Announces Appointment of Matt Valentino as Chief People Officer
-
Bebuzee’s Revolutionary Super App Will Disrupt US and European Markets
-
New York Jets Announce Multi-Year Partnership with VitaCholine®
-
College Innovation Network Celebrates Four Years of Transformative Impact on Higher Education
-
Over $25 Billion in California Farmland Transactions Analyzed in Inaugural Report
-
Akoya Biosciences and Shanghai KR Pharmtech Announce Chinese Regulatory Agency Premarket Approval for KR-HT5 in China to Support Next Generation Pathology Clinical Workflows
-
CALL FOR SUBMISSIONS: 2024 Hillsdale Investment Management – CFA Society Toronto Research Award
-
NewAmsterdam Pharma to Host R&D Day with Key Opinion Leaders on May 16, 2024
-
CareCloud and NJ Comprehensive Healthcare Partner for Operational Efficiency and Cost Reduction
-
FOREWARN Partners with Virginia REALTORS®
-
Alterra IOS Venture III raises $925 million, surpassing $750 million target and increasing hard cap beyond $850 million
